Effects of etomidate on descending activation of motoneurons in neonatal rat spinal cord in vitro.
- Author:
Chao ZHENG
1
;
Meng-Ya WANG
Author Information
1. Wannan Medical College, Wuhu, China.
- Publication Type:Journal Article
- MeSH:
Anesthetics, Intravenous;
pharmacology;
Animals;
Animals, Newborn;
Efferent Pathways;
physiology;
Electric Stimulation;
Etomidate;
pharmacology;
Excitatory Postsynaptic Potentials;
drug effects;
physiology;
Female;
In Vitro Techniques;
Male;
Motor Neurons;
physiology;
Rats;
Rats, Sprague-Dawley;
Receptors, N-Methyl-D-Aspartate;
drug effects;
physiology;
Spinal Cord;
physiology
- From:
Acta Physiologica Sinica
2012;64(2):155-162
- CountryChina
- Language:Chinese
-
Abstract:
Descending activation pathways in spinal cord are essential for inducing and modulating autokinesis, but whether the effects of general anesthetic agents on the descending pathways are involved in initiation of skeletal muscle relaxation or not, as well as the underlying mechanisms on excitatory amino acid receptors still remain unclear. In order to explore the mechanisms underlying etomidate's effects on descending activation of spinal cord motoneurons (MNs), the conventional intracellular recording techniques in MNs of spinal cord slices isolated from neonatal rats (7-14 days old) were performed to observe and analyze the actions of etomidate on excitatory postsynaptic potential (EPSP) elicited by electrical stimulation of the ipsilateral ventrolateral funiculus (VLF), which was named VLF-EPSP. Etomidate at 0.3, 3.0 (correspond to clinical concentration) and 30.0 µmol/L were in turn perfused to MN with steadily recorded VLF-EPSPs. At low concentration (0.3 µmol/L), etomidate increased duration, area under curve and/or half-width of VLF-EPSP and N-methyl-D-aspartate (NMDA) receptor-mediated VLF-EPSP component (all P < 0.05), as well as amplitude, area under curve and half-width of non-NMDA receptor-mediated VLF-EPSP component (all P < 0.05), or decreased amplitude and area under curve of VLF-EPSP, its NMDA receptor component, and non-NMDA receptor component (all P < 0.05). However, at 3.0 and 30.0 µmol/L, it was only observed that etomidate exerted inhibitory effects on amplitude and/or duration and/or area under curve of VLF-EPSP (P < 0.05 or P < 0.01) with concentration- and time-dependent properties. Moreover, NMDA receptor-mediated VLF-EPSP component was more sensitive to etomidate at ≥ 3.0 µmol/L than non-NMDA receptor-mediated VLF-EPSP component did. As a conclusion, etomidate, at different concentrations, exerts differential effects on VLF-EPSP and glutamate receptors mediating the synaptic transmission of descending activation of MNs in neonatal rat spinal cord in vitro.
